Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Recruiting
Observational Study
Biomarkers
Lung Adenocarcinoma
Pleural Effusion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Fu Jen Catholic University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients requiring thoracentesis for pleural effusion drainage as determined by a physician based on clinical need.
* Signed informed consent.
Exclusion Criteria:
* Patients under the age of 18.
* Patients with malignancies other than lung adenocarcinoma.
Contacts